Signaling inhibitors in the clinic: new agents and new challenges.
Hudes
G
G
D017321:Clinical Trials, Phase I as Topic; D006131:Growth Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007555:Isoxazoles / Q000378:metabolism / Q000494:pharmacology*; D000077339:Leflunomide; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D010766:Phosphorylation; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D015398:Signal Transduction / Q000187:drug effects*
D006131:Growth Inhibitors; D007555:Isoxazoles; D020794:Receptor Protein-Tyrosine Kinases; D000077339:Leflunomide